Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Abbott Labs (ABT) PT Raised to $140 at Cowen
January 27, 2021 4:24 PM ESTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $113.00) while maintaining a Outperform rating.
The analyst comments "ABT finished 2020 with 28% organic sales growth and guided to 2021 EPS growth of more than 35%, which still looks conservative. We have... More
